IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBTQ)

CUSIP: 449778109

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 6 signals
Share change
-2,058,811
SEC-reported price per share
$1.73
Number of holders
17
Value change
-$3,558,302
Number of buys
5
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
79,751,533

Security key

449778109

Report period

Q1 2024

Institutions

17

Top holders

10

Ownership snapshot

Top reported holders of IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invest A/s Lundbeckfond
Disclosed value leader
Invest A/s Lundbeckfond
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $14,438,960 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Invest A/s Lundbeckfond has the largest disclosed position value at $14.44M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invest A/s Lundbeckfond's linked filing trail.
Disclosed position value Top 5
Invest A/s Lundbeckfond $14.44M
Vivo Capital IX, LLC $9.51M
HBM Healthcare Investments (Cayma... $2.78M
Kurma Partners $645.2K
Vivo Capital, LLC $11.61M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invest A/s Lundbeckfond
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$14,438,960
21,851,920 shares
mixed-class rows
— 09 Aug 2023
Vivo Capital IX, LLC
3/4/5
10%+ Owner
—
mixed-class rows
$9,510,598
12,346,878 shares
mixed-class rows
— 09 Aug 2023
HBM Healthcare Investments (Cayman) Ltd.
3/4/5
10%+ Owner
—
denominator unverified
$2,784,714
2,690,545 shares
— 09 Nov 2021
Kurma Partners
3/4/5
10%+ Owner
—
denominator unverified
$645,248
623,428 shares
— 09 Aug 2023
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$11,606,065
6,173,439 shares
— 31 Dec 2023
Novo Holdings A/S
13F
Company
13F
—
denominator unverified
$10,804,486
5,747,067 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
17
Shares
27,341,910
Rows available
17
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2026 Across Filers

Q1 2026 holders
12
Q1 2024 holders
17
Holder diff
5
Investor Q1 2026 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2026 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .